Exacerbation of delayed-type hypersensitivity responses in EBV-induced gene-3 (EBI-3)-deficient mice

Immunology Letters

Volumn 128, Issue 2, 2010, Pages 108-115

  Tong, Honglian ^a,b   Miyazaki, Yoshiyuki ^b   Yamazaki, Masanori ^b   Hara, Hiromitsu ^b   Waldmann, Herman ^c   Hori, Shohei ^d   Yoshida, Hiroki ^b  

^a NANCHANG UNIVERSITY   (China)

^b SAGA UNIVERSITY   (Japan)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

Cytokine; Delayed type hypersensitivity; Epstein Barr virus induced gene 3 (EBI 3); IL 27; IL 35; Inflammation

Indexed keywords

CD69 ANTIGEN; CYTOKINE; GAMMA INTERFERON; HERMES ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P35; INTERLEUKIN 17; INTERLEUKIN 27; INTERLEUKIN 35; L SELECTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DELAYED HYPERSENSITIVITY; DISEASE EXACERBATION; EFFECTOR CELL; EPSTEIN BARR VIRUS INDUCED GENE 3; FOOT PAD; GENE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOREGULATION; INFLAMMATORY INFILTRATE; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH1 CELL; TH17 CELL; WILD TYPE;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FOOT; HERPESVIRUS 4, HUMAN; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSION; LYMPH NODES; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, CYTOKINE; SERUM ALBUMIN, BOVINE; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 77249097317     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2010.01.001     Document Type: Article

References (36)

1. Pflanz S., Timans J.C., Cheung J., Rosales R., Kanzler H., Gilbert J., et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity 2002, 16:779-790.
2. Pflanz S., Hibbert L., Mattson J., Rosales R., Vaisberg E., Bazan J.F., et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol 2004, 172:2225-2231.
3. Yoshida H., Hamano S., Senaldi G., Covey T., Faggioni R., Mu S., et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 2001, 15:569-578.
4. + T cells partially through STAT3-dependent mechanism. J Immunol 2006, 177:5377-5385.
5. Hamano S., Himeno K., Miyazaki Y., Ishii K., Yamanaka A., Takeda A., et al. WSX-1 is required for resistance to Trypanosoma cruzi infection by regulation of proinflammatory cytokine production. Immunity 2003, 19:657-667.
6. Yamanaka A., Hamano S., Miyazaki Y., Ishii K., Takeda A., Mak T.W., et al. Hyperproduction of proinflammatory cytokines by WSX-1-deficient NKT cells in concanavalin A-induced hepatitis. J Immunol 2004, 172:3590-3596.
7. Miyazaki Y., Inoue H., Matsumura M., Matsumoto K., Nakano T., Tsuda M., et al. Exacerbation of experimental allergic asthma by augmented Th2 responses in WSX-1-deficient mice. J Immunol 2005, 175:2401-2407.
8. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
9. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 6:1123-1132.
10. Stumhofer J.S., Silver J.S., Laurence A., Porrett P.M., Harris T.H., Turka L.A., et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007, 8:1363-1371.
11. Stumhofer J.S., Laurence A., Wilson E.H., Huang E., Tato C.M., Johnson L.M., et al. Interleukin 27 negatively regulates the development of interleukin 17-producing T helper cells during chronic inflammation of the central nervous system. Nat Immunol 2006, 7:937-945.
12. Batten M., Li J., Yi S., Kljavin N.M., Danilenko D.M., Lucas S., et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 2006, 7:929-936.
13. Villarino A.V., Stumhofer J.S., Saris C.J., Kastelein R.A., de Sauvage F.J., Hunter C.A. IL-27 limits IL-2 production during Th1 differentiation. J Immunol 2006, 176:237-247.
14. Owaki T., Asakawa M., Kamiya S., Takeda K., Fukai F., Mizuguchi J., et al. IL-27 suppresses CD28-mediated [correction of medicated] IL-2 production through suppressor of cytokine signaling 3. J Immunol 2006, 176:2773-2780.
15. Fitzgerald D.C., Zhang G.X., El-Behi M., Fonseca-Kelly Z., Li H., Yu S., et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat Immunol 2007, 8:1372-1379.
16. Awasthi A., Carrier Y., Peron J.P., Bettelli E., Kamanaka M., Flavell R.A., et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat Immunol 2007, 8:1380-1389.
17. Batten M., Kljavin N.M., Li J., Walter M.J., de Sauvage F.J., Ghilardi N. Cutting edge: IL-27 is a potent inducer of IL-10 but not FoxP3 in murine T cells. J Immunol 2008, 180:2752-2756.
18. Yoshida H., Yoshiyuki M. Regulation of immune responses by interleukin-27. Immunol Rev 2008, 226:234-247.
19. Devergne O., Hummel M., Koeppen H., Le Beau M.M., Nathanson E.C., Kieff E., et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol 1996, 70:1143-1153.
20. Devergne O., Birkenbach M., Kieff E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci USA 1997, 94:12041-12046.
21. Collison L.W., Workman C.J., Kuo T.T., Boyd K., Wang Y., Vignali K.M., et al. The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature 2007, 450:566-569.
22. Niedbala W., Wei X.Q., Cai B., Hueber A.J., Leung B.P., McInnes I.B., et al. IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells. Eur J Immunol 2007, 37:3021-3029.
23. Miyazaki Y., Shimanoe Y., Wang S., Yoshida H. Amelioration of delayed-type hypersensitivity responses by IL-27 administration. Biochem Biophys Res Commun 2008, 373:397-402.
24. Igawa T., Nakashima H., Sadanaga A., Masutani K., Miyake K., Shimizu S., et al. Deficiency in EBV-induced gene 3 (EBI3) in MRL/lpr mice results in pathological alteration of autoimmune glomerulonephritis and sialadenitis. Mod Rheumatol 2009, 19:33-41.
25. Collison L.W., Vignali D.A. Interleukin-35: odd one out or part of the family? Immunol Rev 2008, 226:248-262.
26. Iwakura Y., Ishigame H. The IL-23/IL-17 axis in inflammation. J Clin Invest 2006, 116:1218-1222.
27. McKenzie B.S., Kastelein R.A., Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006, 27:17-23.
28. Nakae S., Komiyama Y., Nambu A., Sudo K., Iwase M., Homma I., et al. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 2002, 17:375-387.
29. Mohan K., Cordeiro E., Vaci M., McMaster C., Issekutz T.B. CXCR3 is required for migration to dermal inflammation by normal and in vivo activated T cells: differential requirements by CD4 and CD8 memory subsets. Eur J Immunol 2005, 35:1702-1711.
30. Grabbe S., Schwarz T. Immunoregulatory mechanisms involved in elicitation of allergic contact hypersensitivity. Immunol Today 1998, 19:37-44.
31. Crabe S., Guay-Giroux A., Tormo A.J., Duluc D., Lissilaa R., Guilhot F., et al. The IL-27 p28 subunit binds cytokine-like Factor 1 to form a cytokine regulating NK and T cell activities requiring IL-6R for signaling. J Immunol 2009, 183:7692-7702.
32. Cooper A.M., Dalton D.K., Stewart T.A., Griffin J.P., Russell D.G., Orme I.M. Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 1993, 178:2243-2247.
33. Irmler I.M., Gajda M., Brauer R. Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J Immunol 2007, 179:6228-6236.
34. Ghilardi N., Kljavin N., Chen Q., Lucas S., Gurney A.L., De Sauvage F.J. Compromised humoral and delayed-type hypersensitivity responses in IL-23-deficient mice. J Immunol 2004, 172:2827-2833.
35. Stumhofer J.S., Hunter C.A. Advances in understanding the anti-inflammatory properties of IL-27. Immunol Lett 2008, 117:123-130.
36. Yang J., Yang M., Htut T.M., Ouyang X., Hanidu A., Li X., et al. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol 2008, 38:1204-1214.